Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock

被引:62
|
作者
Hohn, Andreas [1 ]
Schroeder, Stefan [2 ]
Gehrt, Anna [3 ]
Bernhardt, Kathrin [3 ]
Bein, Berthold [4 ]
Wegscheider, Karl [5 ]
Hochreiter, Marcel [6 ]
机构
[1] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Anaesthesiol Intens Care Palliat Care & Pain, D-44789 Bochum, Germany
[2] Hosp Duren Gem GmbH, Dept Anaesthesiol Intens Care Med & Pain Therapy, D-52351 Duren, Germany
[3] West Coast Hosp, Dept Anesthesiol & Intens Care Med, D-25746 Heide, Germany
[4] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, D-24105 Kiel, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, D-20246 Hamburg, Germany
[6] Univ Heidelberg Hosp, Dept Anesthesiol, D-69120 Heidelberg, Germany
关键词
Procalcitonin; Sepsis; Economical outcomes; Intensive care; RESPIRATORY-TRACT INFECTIONS; VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE PATIENTS; ANTIMICROBIAL RESISTANCE; DISEASES-SOCIETY; CONTROLLED-TRIAL; DURATION; GUIDELINES; EPIDEMIOLOGY; INITIATION;
D O I
10.1186/1471-2334-13-158
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Procalcitonin (PCT)-protocols to guide antibiotic treatment in severe infections are known to be effective. But less is known about the long-term effects of such protocols on antibiotic consumption under real life conditions. This retrospective study analyses the effects on antibiotic use in patients with severe sepsis and septic shock after implementation of a PCT-protocol. Methods: We conducted a retrospective ICU-database search for adult patients between 2005 and 2009 with sepsis and organ dysfunction who where treated accordingly to a PCT-guided algorithm as follows: Daily measurements of PCT (BRAHMS PCT LIA (R); BRAHMS Aktiengesellschaft, Hennigsdorf, Germany). Antibiotic therapy was discontinued if 1) clinical signs and symptoms of infection improved and PCT decreased to <= 1 ng/ml, or 2) if the PCT value was >1 ng/ml, but had dropped to 25-35% of the initial value within three days. The primary outcome parameters were: antibiotic days on ICU, ICU re-infection rate, 28-day mortality rate, length of stay (LOS) in ICU, mean antibiotic costs (per patient) and ventilation hours. Data from 141 patients were included in our study. Primary outcome parameters were analysed using covariance analyses (ANCOVA) to control for effects by gender, age, SAPS II, APACHE II and effective cost weight. Results: From baseline data of 2005, duration of antibiotic therapy was reduced by an average of 1.0 day per year from 14.3 +/- 1.2 to 9.0 +/- 1.7 days in 2009 (p=0.02). ICU re-infection rate was decreased by yearly 35.1% (95% CI -53 to -8.5; p=0.014) just as ventilation hours by 42 hours per year (95% CI -72.6 to -11.4; p=0.008). ICU-LOS was reduced by 2.7 days per year (p<0.001). Trends towards an average yearly reduction of 28-day mortality by -22.4% (95% CI -44.3 to 8.1; p=0.133) and mean cost for antibiotic therapy/patient by -14.3 Euro (95% CI -55.7 to 27.1) did not reach statistical significance. Conclusions: In a real-life clinical setting, implementation of a PCT-protocol was associated with a reduced duration of antibiotic therapy in septic ICU patients without compromising clinical or economical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study
    Maseda, Emilio
    Suarez-de-la-Rica, Alejandro
    Anillo, Victor
    Tamayo, Eduardo
    Garcia-Bernedo, Carlos A.
    Ramasco, Fernando
    Villagran, Maria-Jose
    Maggi, Genaro
    Gimenez, Maria-Jose
    Aguilar, Lorenzo
    Granizo, Juan-Jose
    Buno, Antonio
    Gilsanz, Fernando
    JOURNAL OF CRITICAL CARE, 2015, 30 (03) : 537 - 542
  • [22] Procalcitonin-Guided Antibiotic Therapy for Acute Respiratory Infections
    Morris, Carl
    Paul, Kathleen
    Safranek, Sarah
    AMERICAN FAMILY PHYSICIAN, 2016, 94 (01) : 53 - +
  • [23] Procalcitonin-guided protocol decreased the antibiotic use in paediatric patients with severe bronchiolitis
    Alejandre, Carme
    Balaguer, Monica
    Guitart, Carmina
    Torrus, Isabel
    Felipe, Aida
    Launes, Cristian
    Jose Cambra, Francisco
    Jordan, Iolanda
    ACTA PAEDIATRICA, 2020, 109 (06) : 1190 - 1195
  • [24] Is Procalcitonin-Guided Therapy Associated With Beneficial Outcomes in Critically Ill Patients With Sepsis?
    Kalil, Andre C.
    Van Schooneveld, Trevor C.
    CRITICAL CARE MEDICINE, 2018, 46 (05) : 811 - 812
  • [25] Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock
    Huang, Min-Yi
    Chen, Chun-Yu
    Chien, Ju-Huei
    Wu, Kun-Hsi
    Chang, Yu-Jun
    Wu, Kang-Hsi
    Wu, Han-Ping
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [26] Procalcitonin-guided antibiotic treatment in critically ill patients
    Andreas Hohn
    Bernhard Heising
    Jan-Karl Schütte
    Olaf Schroeder
    Stefan Schröder
    Langenbeck's Archives of Surgery, 2017, 402 : 1 - 13
  • [27] Procalcitonin-guided antibiotic treatment in critically ill patients
    Hohn, Andreas
    Heising, Bernhard
    Schuette, Jan-Karl
    Schroeder, Olaf
    Schroeder, Stefan
    LANGENBECKS ARCHIVES OF SURGERY, 2017, 402 (01) : 1 - 13
  • [28] PROCALCITONIN-GUIDED ANTIBIOTIC DE-ESCALATION IN SEPTIC ICU PATIENTS IN A VETERANS AFFAIRS HOSPITAL
    Hong, Steven
    Lang, Courtney
    Neff, Margaret
    Nakasone, Trisha
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 617 - 617
  • [29] EFFECT OF PROCALCITONIN-GUIDED ANTIBIOTIC THERAPY IN THE INTENSIVE CARE UNIT
    Amin, Shriji
    Pasternak, Agnieszka
    Yuen, Rosanna
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 328 - 328
  • [30] Prognostic value of procalcitonin in severe sepsis and septic shock
    Julian-Jimenez, A.
    Laserna-Mendieta, E. J.
    Timon-Zapata, J.
    Pedrosa Guerrero, A.
    MEDICINA INTENSIVA, 2013, 37 (02) : 123 - 124